[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_685 

# __Medical researchers__

## Category to which it belongs

* [The various individuals and entities involved in the provision and administration of healthcare services and systems.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_240.md)

## Closest similar item

* [Healthcare researcher](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1164.md)
* [Healthcare researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1854.md)
* [Medical doctors](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Medical professional](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_425.md)
* [Medical professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_499.md)
* [Physicians](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1984.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_355.md)
* [Researchers/public health agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_137.md)
* [Scientists and researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_138.md)
* [Scientists/researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1481.md)

## Risk affecting this stakeholder

* [Acceleration of testing kit development using ai](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2046.md)
* [Application of ai in medical research and social context during pandemic](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5048.md)
* [Challenges in sharing medical data at the individual patient level](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6086.md)
* [Close similarities observed between historical guidance and 2007 guidance in pandemic preparedness planning.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6680.md)
* [Dependence of uv doses on type of organism and hard surface](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6683.md)
* [Dependence on wearable technology for disease detection may lead to neglect of traditional diagnostic methods and clinical assessment.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6751.md)
* [Deposition of droplets in respiratory system](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6782.md)
* [Difficulty in determining the risk and severity of infection based on viral exposure and deposition in the respiratory system](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7111.md)
* [Difficulty in sharing individual patient-level data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7924.md)
* [False identification of potential drug treatments for covid-19 through ai analysis.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7926.md)
* [Inaccurate or incomplete information in the medical and health kgs may lead to misinformed treatment decisions for covid-19.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7928.md)
* [Inadequate data collection and efforts may lead to ineffective management of contagious diseases.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7949.md)
* [Inadequate utilization of urine proteomics for disease biomarkers](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8403.md)
* [Inefficient dissemination of quality research leading to challenges for medical staff](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9366.md)
* [Lack of direct confirmatory evidence of self-inoculation into mucous membranes as the end-stage pathway to infection through droplet and contact transmission routes.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12118.md)
* [Lack of evidence-based research on the recommended use of anti-inflammatory drugs for covid-19 treatment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14238.md)
* [Lack of treatment and resources](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14263.md)
* [Limited use of upper-room uv light in healthcare facilities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_15002.md)
* [Need for treatments and approaches to combat specific viral proteins](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_15994.md)
* [Potential for mutations and evolution of the sars-cov-2 virus in human and animal hosts](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17101.md)
* [Reliance on non-pharmaceutical interventions at the early stage of a pandemic](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17860.md)
* [Reliance on wearable devices for monitoring patients and potential inaccuracies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18669.md)
* [Underutilization of ioht/iomt](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18903.md)
* [Variability in data sharing formats and standards](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19952.md)

## Risks that can be mitigated by this stakeholder

* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1139.md)
* [Lack of effective treatment for baylisascariasis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8113.md)
* [Lack of effective treatment for newly emerging infectious diseases such as covid-19](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9110.md)
* [Reliance on ai and ml for prognosis and biomarker prediction may lead to misinterpretation of results and misinformed treatment decisions.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11002.md)
* [Uncertain long-term toll of coronavirus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19053.md)
* [Unsupervised learning for identifying biological samples and subgroups may result in inaccurate classification and treatment decisions.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19054.md)
* [Use of machine learning algorithms for predicting specific diseases introduces potential for inaccurate predictions.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19055.md)

## This Stakeholder belongs to this Stakeholder Group

* [Research organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_0.md)

## This Stakeholder belongs to this Stakeholder Subgroup

* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/StakeholderSubgroup/PBN__StakeholderSubgroup_5.md)

## Type of the stakeholder

* [At risk](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_2.md)
* [Risk owner](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_1.md)

